Halbert Hargrove Global Advisors’s DexCom DXCM Stock Holding History

Halbert Hargrove Global Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-54	Closed	-$3.63K	–	479
2025 Q3	$3.63K	Buy	+54	New	+$4.27K	﹤0.01%	466
2022 Q1	–	Sell	-1,560	Closed	-$210K	–	170
2021 Q4	$210K	Buy	1,560 +20	+1%	+$2.87K	0.01%	156
2021 Q3	$211K	Buy	+1,540	New	+$194K	0.01%	139

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Halbert Hargrove Global Advisors's DXCM Position: Q4 2025 in Review

Halbert Hargrove Global Advisors sold out of DexCom (DXCM) in Q4 2025, closing a stake of 54 shares — an estimated $3.63K sold.

Halbert Hargrove Global Advisors first reported a position in DXCM in Q3 2021 and held it in 3 quarters. The position peaked at $211K in Q3 2021. 922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

Halbert Hargrove Global Advisors reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
Halbert Hargrove Global Advisors sold 54 DexCom shares in Q4 2025, an estimated $3.63K.
Halbert Hargrove Global Advisors first reported a position in DexCom in Q3 2021 and held it in 3 quarters.
Halbert Hargrove Global Advisors's DexCom position peaked at $211K in Q3 2021.
922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Halbert Hargrove Global Advisors's 13F filing for Q4 2025, filed 23 Jan 2026.